Chembio Diagnostics Inc.
CEMI
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.71M
Close$
Share Statistics
| Market cap | $16.71 Million |
|---|---|
| Enterprise Value | $23.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.96 |
| Beta | 1.86 |
| Outstanding Shares | 24,299,000 |
Return
| Return on Equity | -140.05% |
|---|---|
| Return on Assets | -39.81% |
| Return on Invested Capital | -87.52% |
Valuation & Multiples
| P/E Ratio | -0.47 |
|---|---|
| PEG | 0.5 |
| Price to Sales | 0.46 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | -1.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | 1.41 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Chembio Diagnostics Inc.
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific...